Skip to main content
HIPC & Privacy Act 2020 Compliant

Anxiety & Depression Tools for Aotearoa New Zealand

Validated anxiety and depression screening tools for NZ psychologists, counsellors, and GPs. Auto-scored with clinical cutoffs, designed for routine outcome monitoring in primary care and private practice.

GAD-7 (89% Sensitivity)
PHQ-9 (88% Sensitivity)
Auto-Scored
HIPC Compliant
Free to Start

Primary Care in Aotearoa

Anxiety and Depression Are the Most Common Mental Health Conditions in NZ

One in five New Zealanders will experience a mood or anxiety disorder in their lifetime. Efficient, validated screening tools help practitioners identify and monitor these conditions early — supporting better outcomes across primary care, counselling, and specialist settings.

Screening Tools Available

Validated tools covering anxiety, depression, and psychological distress — from quick screening to comprehensive outcome monitoring.

GAD-7 — Generalised Anxiety Disorder

Most Used

The GAD-7 is the gold-standard brief screening tool for generalised anxiety disorder. Widely used in NZ primary care and specialist settings for initial screening and treatment monitoring.

89%

Sensitivity

82%

Specificity

2-3 min

Completion Time

7 ItemsAuto-ScoredClinical CutoffsFree Test Available

PHQ-9 — Patient Health Questionnaire (Depression)

Free Test Available

The PHQ-9 is the most widely used depression screening tool in NZ primary care. Nine items mapping to DSM-5 criteria for major depressive disorder, with validated severity cutoffs for clinical decision-making.

88%

Sensitivity

88%

Specificity

3-5 min

Completion Time

9 ItemsDSM-5 AlignedAuto-ScoredSeverity Bands

DASS-21 — Depression, Anxiety & Stress Scale

A comprehensive 21-item tool that screens for depression, anxiety, and stress simultaneously. Popular in NZ research and clinical settings for its ability to differentiate between three related but distinct domains.

21 Items3 SubscalesAuto-ScoredSeverity Cutoffs~5 min

K10 & CORE-10 — Outcome Monitoring

The Kessler Psychological Distress Scale (K10) and CORE Outcome Measure (CORE-10) are designed for routine outcome monitoring. Track psychological wellbeing over time to measure treatment progress — widely used in NZ counselling and community mental health settings.

K10 (10 Items)CORE-10 (10 Items)Repeated MeasuresTrack Progress

Used Across NZ Clinical Settings

Anxiety and depression screening is standard practice across primary care, private practice, and community mental health in Aotearoa.

GPs & Primary Care

Quick screening with GAD-7 and PHQ-9 during consultations. Identify patients who need further assessment or referral — supports the primary care mental health pathway.

Counsellors & Therapists

Routine outcome monitoring with K10 and CORE-10. Track treatment progress across sessions and demonstrate outcomes — increasingly expected by NZ professional bodies and funders.

Psychologists & Psychiatrists

Comprehensive baseline assessments with DASS-21. Pre-appointment screening saves session time and provides structured data for clinical documentation and treatment planning.

How Anxiety & Depression Screening Works

1

Create your free account

Sign up in 2 minutes. Set New Zealand as your country and accept terms. No credit card needed — your free tier includes 10 responses.

2

Choose the right screening tool

Select GAD-7 for anxiety, PHQ-9 for depression, DASS-21 for combined screening, or K10/CORE-10 for routine outcome monitoring. All forms are pre-configured and ready to send.

3

Send a secure link to your patient

Generate a unique assessment link. Your patient completes it on their own device — at home before the appointment, in the waiting room, or during a telehealth session.

4

Review auto-scored results

Responses are automatically scored with validated clinical cutoffs. Severity bands (minimal, mild, moderate, severe) are clearly displayed to support your clinical decision-making.

Why Practitioners Choose ClientForms

Purpose-built for clinical screening in the New Zealand healthcare context.

HIPC Compliant

Built to meet the Health Information Privacy Code 2020 and NZ Privacy Act 2020. All data hosted in Australia — comparable safeguards under IPP 12.

Instant Auto-Scoring

No manual scoring required. Responses are automatically calculated with validated severity bands — saving time and eliminating scoring errors.

Neurodivergent-Friendly

Research-backed UX designed with neurodivergent patients in mind. Clear progress indicators, time estimates, and reduced cognitive load — supporting holistic hauora for all patients.

Anxiety and depression often co-occur with ADHD and autism

Research shows that up to 50% of adults with ADHD also experience anxiety or depression. ClientForms provides a comprehensive assessment library covering ADHD, autism, anxiety, depression, and more — all on one platform.

Frequently Asked Questions

What anxiety and depression screening tools are available?

ClientForms provides GAD-7 (generalised anxiety, 89% sensitivity), PHQ-9 (depression, 88% sensitivity), DASS-21 (combined depression, anxiety, and stress), K10 (psychological distress), and CORE-10 (clinical outcomes). All tools are auto-scored with validated clinical cutoffs and HIPC compliant.

What is the difference between GAD-7 and DASS-21?

The GAD-7 is a 7-item tool specifically targeting generalised anxiety disorder — ideal for quick screening in primary care. The DASS-21 is a broader 21-item tool that measures depression, anxiety, and stress as three separate subscales. Use GAD-7 for focused anxiety screening; DASS-21 for a more comprehensive picture.

Can I track treatment progress over time?

Yes. Tools like K10 and CORE-10 are specifically designed for routine outcome monitoring. Send the same assessment at regular intervals (e.g., every 4 weeks) and compare scores to track treatment response. ClientForms stores all responses in your dashboard for easy comparison.

Are these tools suitable for telehealth?

Yes. Practitioners generate a secure assessment link and send it to their patient. Patients complete the screening on their own device — at home, in the waiting room, or during a telehealth session. This is ideal for reaching patients across Aotearoa, including rural and underserved communities.

Is my patient data safe?

All clinical data is stored in Australia (Sydney) on enterprise-grade infrastructure with AES-256 encryption. Australia provides comparable privacy safeguards to NZ under Information Privacy Principle 12. No data is sent to the US or EU. ClientForms is built to comply with the NZ Privacy Act 2020 and HIPC 2020.

Start Screening Today

Join practitioners across Aotearoa New Zealand using ClientForms for validated anxiety and depression screening. Free tier available — set up in 2 minutes.